Junping Hong

State Key Laboratory Of Vaccines For Infectious Diseases, State Key Laboratory Of Molecular Vaccinology And Molecular Diagnostics
Xiamen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Correction: The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors.

Correction: The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 23, 2023

Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes.

Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes.

Journal: Emerging microbes & infections

Published: August 05, 2023

The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors.

The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 05, 2023

Affinity Exploration of SARS-CoV-2 RBD Variants to mAb-Functionalized Plasmonic Metasurfaces for Label-Free Immunoassay Boosting.

Affinity Exploration of SARS-CoV-2 RBD Variants to mAb-Functionalized Plasmonic Metasurfaces for Label-Free Immunoassay Boosting.

Journal: ACS nano

Published: January 11, 2023

Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection.

Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection.

Journal: Cell reports. Medicine

Published: September 13, 2022

Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion.

Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 02, 2022

Urgency and necessity of Epstein-Barr virus prophylactic vaccines.

Urgency and necessity of Epstein-Barr virus prophylactic vaccines.

Journal: NPJ vaccines

Published: July 26, 2022

A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus.

A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus.

Journal: Virology journal

Published: July 26, 2022

Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells.

Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells.

Journal: Frontiers in immunology

Published: April 14, 2022

A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo.

A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo.

Journal: Journal of virology

Published: March 29, 2022

A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2.

A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2.

Journal: Science bulletin

Published: February 21, 2022

Antibody Generation and Immunogenicity Analysis of EBV gp42 N-Terminal Region.

Antibody Generation and Immunogenicity Analysis of EBV gp42 N-Terminal Region.

Journal: Viruses

Published: October 05, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026